// App-Quantinova.ai

EXTH-57 : EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

Researchers

Presenter

  • Greg Palmer

Principal Investigators

  • Stephen T Keir

  • David M Ashley

  • Rhian Davies

  • Ben Williams

  • Zoe Rees

  • Keith Laemont

  • Rafaela Belloni

  • Stephen J P Damment

  • Kelly Conlon

Medical Centers

  • Duke University, Raleigh, USA

  • Midatech Pharma, Cardiff, UK

  • The Preston Robert Tisch Brain Tumor Center, Duke University, Raleigh, NC, USA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Glioblastoma

  • Acro–dermato–ungual–lacrimal–tooth (ADULT) syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Panobinostat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved